Consistent with this, prior research has established that the pharmacological inhibition of PI3Kγ/p110γ with small-molecule agents potently attenuates PI3K/Akt signaling in human and murine leukemia cells, macrophages, and T cells [46,47,48]. This evidence concerns the gene AKT1 and leukemia.